Literature DB >> 6205031

Biochemical markers in suicidal patients. Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests.

C M Banki, M Arató, Z Papp, M Kurcz.   

Abstract

141 female psychiatric patients, suffering from major depression, schizophrenia, alcohol dependence or adjustment disorder, were investigated for their 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA) and cortisol level in the cerebrospinal fluid (CSF). Dexamethasone suppression tests were also performed in 111 cases, and TRH/TSH tests in 40 subjects. Fifty-two patients were hospitalized following a recent suicide attempt, 18 of which were made using a violent method. The other 34 attempters took tranquilizer or sedative overdoses. CSF 5-HIAA was significantly lower in violent attempters in all 4 diagnostic categories. CSF HVA was higher in those taking drug overdoses, but only in depression (and less markedly in schizophrenia). CSF cortisol did not differ among either diagnostic or suicidal subgroups. Dexamethasone suppression was more frequently abnormal in suicidal patients than in nonattempters, and this difference was more important where the overall nonsuppression rate was lower. Maximal TSH response to TRH showed an inverse correlation with CSF 5-HIAA, and it was lowest in the nonattempter group. The difference between violent suicide attempters and nonattempters in their TSH response was significant. Since these biochemical changes were more or less independent of clinical diagnoses, it seems relevant to explore further the biological background of human aggression and suicide as a separate research direction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205031     DOI: 10.1016/s0165-0327(84)80012-9

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  12 in total

1.  Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex.

Authors:  M D Galva; G P Bondiolotti; M Olasmaa; G B Picotti
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 2.  The dimensional approach to clinical psychopharmacology: a polysemous concept.

Authors:  P Baruch; M J Filteau; R H Bouchard; E Pourcher; P Vincent; R Jouvent
Journal:  J Psychiatry Neurosci       Date:  1992-06       Impact factor: 6.186

3.  What can post-mortem studies tell us about the pathoetiology of suicide?

Authors:  Ghanshyam N Pandey; Yogesh Dwivedi
Journal:  Future Neurol       Date:  2010-09

Review 4.  Genetic and biologic risk factors for suicide in depressive disorders.

Authors:  A Roy
Journal:  Psychiatr Q       Date:  1993

5.  Serum lipid profile in suicide attempters.

Authors:  S Verma; J K Trivedi; H Singh; P K Dalal; O P Asthana; J S Srivastava; R Mishra; P K Sinha
Journal:  Indian J Psychiatry       Date:  1999-10       Impact factor: 1.759

6.  Reduction in suicidal ideation with SSRIs: a review of 459 depressed patients.

Authors:  M J Filteau; Y D Lapierre; D Bakish; A Blanchard
Journal:  J Psychiatry Neurosci       Date:  1993-05       Impact factor: 6.186

Review 7.  Dopamine and depression.

Authors:  A S Brown; S Gershon
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 8.  Biological basis of suicide and suicidal behavior.

Authors:  Ghanshyam N Pandey
Journal:  Bipolar Disord       Date:  2013-06-15       Impact factor: 6.744

Review 9.  Serotonergic modulation of suicidal behaviour: integrating preclinical data with clinical practice and psychotherapy.

Authors:  Vasileios Boulougouris; Ioannis Malogiannis; George Lockwood; Iannis Zervas; Giuseppe Di Giovanni
Journal:  Exp Brain Res       Date:  2013-08-23       Impact factor: 1.972

Review 10.  The neurobiology of suicide - A Review of post-mortem studies.

Authors:  Karolina Furczyk; Barbora Schutová; Tanja M Michel; Johannes Thome; Andreas Büttner
Journal:  J Mol Psychiatry       Date:  2013-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.